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Abstract
Clinical isolates of Staphylococcus aureus can express biofilm phenotypes promoted by the major cell wall autolysin and the
fibronectin-binding proteins or the icaADBC-encoded polysaccharide intercellular adhesin/poly-N-acetylglucosamine (PIA/
PNAG). Biofilm production in methicillin-susceptible S. aureus (MSSA) strains is typically dependent on PIA/PNAG whereas
methicillin-resistant isolates express an Atl/FnBP-mediated biofilm phenotype suggesting a relationship between susceptibility
to b-lactam antibiotics and biofilm. By introducing the methicillin resistance gene mecA into the PNAG-producing laboratory
strain 8325-4 we generated a heterogeneously resistant (HeR) strain, from which a homogeneous, high-level resistant (HoR)
derivative was isolated following exposure to oxacillin. The HoR phenotype was associated with a R602H substitution in the
DHHA1 domain of GdpP, a recently identified c-di-AMP phosphodiesterase with roles in resistance/tolerance to b-lactam
antibiotics and cellenvelopestress. Transcriptionof icaADBCand PNAG production were impaired in the 8325-4HoR derivative,
which instead produced a proteinaceous biofilm that was significantly inhibited by antibodies against the mecA-encoded
penicillin binding protein 2a (PBP2a). Conversely excision of the SCCmec element in the MRSA strain BH1CC resulted in oxacillin
susceptibilityand reduced biofilmproduction, bothof whichwerecomplementedbymecAalone.Transcriptionalactivityof the
accessory gene regulator locus was also repressed in the 8325-4 HoR strain, which in turn was accompanied by reduced
protease production and significantly reduced virulence in a mouse model of device infection. Thus, homogeneous methicillin
resistance has the potential to affect agr-a n dicaADBC-mediated phenotypes, including altered biofilm expression and
virulence, which together are consistent with the adaptation of healthcare-associated MRSA strains to the antibiotic-rich
hospital environment in which they are frequently responsible for device-related infections in immuno-compromised patients.
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Introduction
Infections caused by healthcare-associated Staphylococcus aureus
and methicillin resistant S. aureus (MRSA) pose a major threat to
hospital patients. A significant risk factor for these healthcare-
associated infections is the extensive use of implanted prosthetic
biomaterials for diagnostic and therapeutic purposes, which can be
colonized by staphylococci giving rise to device-related infections
(DVIs) involving biofilms [1]. In addition to resistance to b-lactam
antibiotics such as oxacillin, current chemotherapeutics for DVIs
have limited effectiveness against biofilms.
The challenge of developing therapeutics to treat staphylococcal
biofilm infections is compounded by the existence of multiple
biofilm mechanisms in both S. aureus and S. epidermidis. Thus,
although production of the exopolysaccharide polysaccharide
intercellular adhesin (PIA) or polymeric N-acetyl-glucosamine
(PNAG) synthesized and exported by proteins encoded by the
icaADBC genes is common among clinical isolates of both species
[2,3,4,5,6], ica-independent biofilm production has also been
described under in vitro conditions [1]. Using clinical isolates of S.
aureus, we reported that methicillin resistant S. aureus (MRSA)
strains express an icaADBC-independent biofilm phenotype in vitro
[3,4], which is instead dependent on the fibronectin binding
proteins (FnBPA and FnBPB) and the major autolysin (Atl) [6,7].
Atl-dependent autolytic activity and extracellular DNA release are
involved in the early stages of biofilm production by these MRSA
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accumulation and biofilm maturation [6,7]. Unlike MRSA,
clinical isolates of methicillin susceptible S. aureus (MSSA) express
a PNAG-dependent biofilm phenotype on hydrophilic surfaces
and an Atl/PNAG-dependent biofilm on hydrophobic surfaces.
Other staphylococcal surface proteins implicated in biofilm
include the biofilm-associated protein (Bap, in bovine S. aureus
isolates), accumulation-associated protein (Aap) of S. epidermidis and
its S. aureus homologue SasG [8,9,10,11], protein A [12], SasC [13]
and the extracellular matrix binding protein (Embp) of S.
epidermidis [14]. The growing number of bacterial factors involved
in staphylococcal biofilm development underscores the importance
of this phenotype to the pathogen and suggests that there may be
redundancy between biofilm mechanisms in different clinical
isolates or on different surfaces.
The methicillin resistance gene mecA encodes the low affinity
penicillin binding protein 2a carried on a mobile staphylococcal
cassette chromosomal mec element (SCCmec) [15] of which eight
different types have been characterized to date [16]. Heterogene-
ity is a feature of S. aureus methicillin resistance [17,18,19]. Many
S. aureus clinical isolates exhibit heterogeneous methicillin
resistance (HeR) under laboratory growth conditions. In a HeR
strain the majority of cells grown in the presence of a b-lactam
antibiotic are susceptible to low concentrations of the drug, with
only a subpopulation expressing higher-level resistance. However
HeR strains become capable of expressing homogeneous resis-
tance (HoR) after selection on elevated concentrations of b-lactam
antibiotics or under specific growth conditions [20]. This transition
from HeR to HoR is complex with mutations at the fem (factor
essential for methicillin resistance), aux (auxiliary) and tagO loci all
being implicated [21,22,23]. In addition, an oxacillin-induced
increased SOS response was shown to increase the mutation rate
during HeR to HoR selection in a mechanism dependent on the
accessory gene regulator Agr [24,25]. Nevertheless because HoR
clinical isolates are not deficient in any of these accessory factors
and because mutations at these loci alone are insufficient to
explain HeR to HoR selection, the mechanism underpinning this
phenomenon is clearly complex.
SCCmec elements can also carry resistance genes for other
antibiotics and heavy metals as well as the psm-mec locus, which
encodes a cytolysin termed phenol-soluble modulin-mec (PSM-
mec) [26]. Carriage of the psm-mec locus from type II SCCmec
elements attenuates virulence, suppresses colony spreading
activity, reduces expression of the chromosomally encoded PSMa
and promotes biofilm formation [26,27,28]. Furthermore both the
psm-mec encoded RNA and the PSM-mec peptide contribute to the
pleiotropic role of this locus [27,28].
Our analysis of S. aureus clinical isolates identified a novel biofilm
phenotype expressed by MRSA clinical isolates in which the major
cell wall autolysin Atl and the fibronectin-binding proteins FnBPA
and FnBPB have fundamental functions [3,6,7]. The Atl/FnBP
biofilm phenotype appears to be absent or less prevalent among
methicillin-susceptible S. aureus (MSSA) isolates, which produce
PNAG-dependent biofilms in vitro. Interestingly the psm-mec locus
from a type II SCCmec element increased expression of FnBPA in
the MSSA strain Newman [28]. However because clinical MRSA
isolates that produce an FnBP-dependent biofilm [4,6] can contain
either type II (psm-mec
+) or type IV (psm-mec
2) SCCmec elements
[27,28], itseemsunlikely that carriage of the psm-meclocus alone can
explain the expression of Atl/FnBP- or PNAG-dependent biofilm
phenotypes by MRSA and MSSA clinical isolates, respectively.
Furthermore when considered with earlier reports suggesting a
correlation between b-lactam resistance and biofilm [29,30,31,32]
our data raise the question as to whether methicillin susceptibility
itself influences biofilm and if so, how.
Here we investigated the impact of acquisition of PBP2a-
induced homogeneous oxacillin resistance on biofilm and
virulence in the laboratory MSSA strain 8325-4. Genetic changes
associated with the HoR phenotype in 8325-4 were identified by
whole genome sequencing. The biofilm phenotypes of 8325-4 and
its HoR derivative were compared and the impact of HoR
oxacillin resistance on transcription of the icaADBC and agr loci
examined. The impact of loss of SCCmec and methicillin
susceptibility on the biofilm phenotype of the MRSA strain
BH1CC was also examined. Extracellular protease production by
8325-4 and 8325-4 HoR was measured and the virulence of both
strains compared in a mouse model of device-related infection.
Our data reveal that expression of homogeneous methicillin
resistance in S. aureus influences the biofilm phenotype and
attenuates virulence.
Results
Impact of induced oxacillin susceptibility on MRSA
biofilm production
To investigate the relationship between susceptibility to b-
lactam antibiotics and the biofilm phenotype we used plasmid
pSR2 carrying the ccrAB recombinase genes to promote excision of
SCCmec in the MRSA clinical isolate BH1CC, which contains a
type II SCCmec element and produces an Atl/FnBP-dependent
biofilm in growth media supplemented with glucose [6,7]. Excision
of the SCCmec element in BH1CC resulted in a reduction in the
oxacillin MIC from .100 mg/ml to ,1 mg/ml (data not shown).
Biofilm assays revealed a significant reduction in biofilm
production by BH1CC DSCCmec in BHI glucose compared to
BH1CC (Figure 1A). Complementation of the DSCCmec mutant
with pmecA restored both oxacillin resistance (data not shown) and
biofilm production in BHI glucose to near wild type levels
(Figure 1A). In contrast pmecAS403A, in which the serine residue
Author Summary
The acquisition of mecA, which encodes penicillin binding
protein 2a (PBP2a) and methicillin resistance, by Staphy-
lococcus aureus has added to an already impressive array
of virulence mechanisms including enzyme and toxin
production, biofilm forming capacity and immune evasion.
And yet clinical data does not indicate that healthcare-
associated methicillin resistant S. aureus (MRSA) strains are
more virulent than their methicillin-susceptible counter-
parts. Here our findings suggest that MRSA sacrifices
virulence potential for antibiotic resistance and that
expression of methicillin resistance alters the biofilm
phenotype but does not interfere with the colonization
of implanted medical devices in vivo. High level expression
of PBP2a, which was associated with a mutation in the c-
di-AMP phosphodiesterase gene gdpP, resulted in these
pleiotrophic effects by blocking icaADBC-dependent poly-
saccharide type biofilm development and promoting an
alternative PBP2a-mediated biofilm, repressing the acces-
sory gene regulator and extracellular protease production,
and attenuating virulence in a mouse device-infection
model. Thus the adaptation of MRSA to the hospital
environment has apparently focused on the acquisition of
antibiotic resistance and retention of biofilm forming
capacity, which are likely to be more advantageous than
metabolically-expensive enzyme and toxin production in
immunocompromised patients with implanted medical
devices offering a route to infection.
Methicillin Resistance and Biofilm in S. aureus
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the Materials and Methods), failed to restore oxacillin resistance
(data not shown) or biofilm production in the BH1CC DSCCmec
mutant (Figure 1A). RT-PCR analysis demonstrated that mecA
mRNA levels were similar in the BH1CC SCCmec mutant
carrying pmecA and pmecAS403A (Figure 1B) indicating that
functional PBP2a and not mecA mRNA was responsible for the
observed phenotypes.
Protease activity in the culture supernatant of BH1CC
DSCCmec was reduced by approximately 50% compared to
BH1CC and was restored to wild type levels by complementation
with pmecA (Figure 1C). In addition the addition of the serine
protease inhibitor dichloroisocoumarin to the growth media
restored biofilm production by the BH1CC DSCCmec mutant
strain in a dose-dependent manner (Figure 1D). Taken together
these data indicate that oxacillin resistance promotes protein
adhesin-dependent biofilm production in BH1CC at least in part
by repressing extracellular protease production.
To determine if these findings could be extended to other clinical
MRSA isolates, we deleted the SCCmec element from six clinical
isolatesinourcollectionthat formed robust biofilm,weregenetically
amenable, had different SCCmec types and were from different
clonalcomplexes. Furthermorewecomplementedallof the SCCmec
mutants with the pmecA plasmid. Our data show that the impact of
the SCCmec mutation on biofilm varied between the strains (Figure
S1). In four strains biofilm production was significantly reduced
whereas in the remaining two strains, biofilm was largely unaffected
(Figure S1). However complementation with the pmecA plasmid
increased biofilm production in all seven SCCmec mutants (Figure
S1). The variable impact of the SCCmec deletions in different strains
may reflect the complexity and multiple mechanisms of S. aureus
biofilm production but nevertheless these data indicate that high
level mecA/PBP2a expression always promoted biofilm production
providing further evidence that methicillin resistance influences the
biofilm phenotype in S. aureus clinical isolates.
Isolation of a homogeneously oxacillin resistant
derivative of S. aureus 8325-4
To investigate the impact of oxacillin resistance on icaADBC/
PNAG-dependent S. aureus biofilm production, we generated a
methicillin (oxacillin) resistant derivative of the laboratory strain
8325-4. 8325-4 was chosen because is it amenable to genetic
manipulation and exclusively produces icaADBC/PNAG-depen-
dent biofilms [4]. The related laboratory strain SH1000 (an rsbU-
repaired derivative of 8325-4 [33]) is capable of PNAG-
independent biofilm production [34,35], while HG003 [36] (an
rsbU- and tcaR-repaired derivative of 8325) exhibited a smooth
colony morphology on Congo red agar and did not produce
detectable levels of PNAG in our experiments (Figure S2).
Transformation of 8325-4 with plasmid pRB474 carrying the
mecA gene expressed from its own promoter (pmecA) was accompa-
nied by heterogeneous resistance (HeR) to oxacillin (data not
shown). A homogeneously, high-level oxacillin-resistant (HoR)
derivative of 8325-4 pmecA was subsequently isolated on BHI media
supplemented with 100 mg/ml oxacillin. Western blot analysis
performed using commercial monoclonal antibody against PBP2a
from Denka-Seiken (Japan) revealed substantially higher PBP2a
levels in 8325-4 pmecA HoR than in 8325-4 pmecA HeR (Figure 2A).
To investigate the genetic basis for the switch from expression of
heterogeneous to homogeneous oxacillin resistance, the genomes of
Figure 1. Impact of methicillin susceptibility on the MRSA
biofilm phenotype. (A) Biofilm phenotypes of BH1CC, BH1CC
DSCCmec, BH1CC DSCCmec pmecA and BH1CC DSCCmec pmecAS403A
grown for 24 h at 37uC in BHI glucose in hydrophilic 96-well polystyrene
plates. (B) Comparison of relative mecA transcription by real time RT-
PCR in BH1CC, BH1CC DSCCmec, BH1CC DSCCmec pmecA and BH1CC
DSCCmec pmecAS403A. Total RNA was extracted from cultures grown
at 37uCt oA600=1 (early exponential phase) in BHI glucose. Experiments
were repeated at least three times and standard deviations are
indicated. (C) Protease activity in culture supernatants of BH1CC,
BH1CC DSCCmec and BH1CC DSCCmec pmecA grown for 8 h at 37uCi n
BHI glucose. (D) Relative biofilm production by BH1CC DSCCmec grown
for 24 h at 37uC in BHI glucose media supplemented with the serine
protease inhibitor dichloroisocoumarin (0–0.5 mM) in hydrophilic 96-
well polystyrene plates compared to BH1CC (control). Experiments were
repeated three times. Standard deviations and significance values are
indicated.
doi:10.1371/journal.ppat.1002626.g001
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aligned totheS.aureusNCTC8325(CP000253)genomesequenceas
described in the Materials and Methods. Briefly one non-
synonymous single nucleotide polymorphism (SNP) was identified
in the gdpP (SAOUHSC_00015) gene of the HoR strain and
confirmed by PCR amplification followed by capillary electropho-
resis sequencing. This SNP results in a R602H substitution in GdpP,
which has recently been identified as a c-di-AMP phosphodiesterase
and implicated in resistance/tolerance to b-lactam antibiotics,
biofilm formation and cell wall architecture [37,38]. Subsequent
characterization of nine independently isolated 8325-4 HoR strains
identified a G308D substitution in seven strains, and D382–504 and
D80–174 deletions in the other two strains. The GdpP R602 and G308
residues are highly conserved across multiple S. aureus species. These
data revealed a strong correlation between high level PBP2a
production and homogeneous oxacillin resistance in 8325-4 and
suggest that gdpP mutations are also required for maximal PBP2a
expression or stability in the 8325-4 pmecA HoR strain.
Impact of mecA-induced oxacillin resistance on biofilm
development
Comparison of the biofilm phenotypes of 8325-4, 8325-4 pmecA
HeR and 8325-4 pmecA HoR under different growth conditions
revealed that homogeneous oxacillin resistance was associated with
a substantial reduction in biofilm forming capacity in BHI and
BHI NaCl (P,0.0001) but that 8325-4 pmecA HoR retained the
capacity to form reduced levels of biofilm in BHI glucose
(Figure 2B). Our previous studies have shown that biofilm
production by 8325-4 is dependent on PNAG under all growth
conditions, whereas glucose-induced biofilm by MRSA isolates is
mediated by protein adhesins [4,6,7]. Thus the loss of NaCl-
induced biofilm was suggestive of impaired PNAG production in
8325-4 pmecA HoR. The reduced levels of biofilm produced by
8325-4 pmecA HoR compared to 8325-4 pmecA HeR in BHI
glucose can be attributed to the altered biofilm phenotype
expressed by this strain, but as described below, both strains
formed similar levels of biofilm under flow conditions in BHI
glucose. The biofilm phenotypes of 8325-4 and 8325-4 pmecA HeR
were similar (Figure 2B) indicating the heterogeneous oxacillin
resistance phenotype was not associated with a change in the
biofilm phenotype. Curing the pmecA plasmid from 8325-4 pmecA
HoR was associated with a return to oxacillin susceptibility and a
restoration of the wild type biofilm phenotype (Figure 2B).
Sodium metaperiodate, which is known to break down PNAG-
dependent biofilms, degraded 8325-4 and 8325-4 pmecA HeR
biofilms grown in BHI, BHI NaCl and BHI glucose, whereas
proteinase K had no significant effect (Figures 2C and D). In
Figure 2. Impact of homogeneous oxacillin resistance on the biofilm phenotype of S. aureus 8325-4. (A) Western blot analysis of PBP2a
levels in 8325-4, 8325-4 pmecA HeR and 8325-4 pmecA HoR. (B) Biofilm phenotypes of 8325-4, 8325-4 pmecA HeR, 8325-4 pmecA HoR and 8325-4
pmecA HoR (cured) grown for 24 h at 37uC in BHI, BHI NaCl and BHI glucose in hydrophilic 96-well polystyrene plates. (C–F) Dispersal of 8325-4 (C),
8325-4 pmecA HeR (D), 8325-4 pmecA HoR (E), 8325-4 pmecA HoR (cured) (F) biofilms grown for 24 h in BHI, BHI NaCl and BHI glucose by sodium
metaperiodate and proteinase K. (G) Biofilm formation by 8325-4, 8325-4 pmecA HeR, 8325-4 pmecA HoR and 8325-4 pmecA HoR (cured) grown for
24 h in BHI glucose in the absence or presence of 500 mg/ml PAS, 0.25 mg/ml DNase I and heat-inactivated (HI) 0.25 mg/ml DNase I. Biofilm assays
were repeated at least three times and standard deviations are indicated. * indicates a statistically significant difference p,0.01.
doi:10.1371/journal.ppat.1002626.g002
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proteinase K (P,0.0001) but not by sodium metaperiodate
(Figure 2E). Biofilms produced by 8325-4 pmecA HoR (cured)
were dispersed by sodium metaperiodate but not proteinase K
(Figure 2F). 8325-4 pmecA HoR biofilms were also inhibited by
growth in the presence of DNase I whereas 8325-4 and 8325-4
pmecA HeR were unaffected (Figure 2G). Furthermore polyanet-
hole sodium sulfonate (PAS), which blocks autolysis (and
consequently eDNA release) [6,7], completely blocked biofilm
production by 8325-4 pmecA HoR but not 8325-4 and 8325-4
pmecA HeR (Figure 2G). Finally, independently isolated 8325-4
pmecA HoR isolates all exhibited the same biofilm phenotype (data
not shown). Taken together these data indicate that acquisition of
homogeneous oxacillin resistance is apparently accompanied by a
switch from PNAG- to protein-mediated biofilm formation and
that in contrast to 8325-4, the 8325-4 pmecA HoR biofilm
phenotype is dependent on autolytic activity and eDNA release
similar to that observed among clinical MRSA isolates expressing
an Atl/FnBP-dependent biofilm [6,7].
A BioFlux system was used to compare biofilm production by
8325-4 pmecA HeR and 8325-4 pmecA HoR grown in BHI NaCl
and BHI glucose under flow conditions. These data showed that
both strains formed abundant and similar levels of biofilm in BHI
glucose (Figure S3). However neither strain was capable of biofilm
production in BHI NaCl media (Figure S3) making it impossible to
determine the contribution of PNAG to the biofilm phenotypes of
both strains using the BioFlux system. The biofilm negative
phenotype in BHI NaCl is likely due to the more hydrophobic
surface of the BioFlux flow cell compared to the very hydrophilic,
tissue-culture treated polystyrene used in our microtitre plate
assay. We have previously reported that 8325-4 is incapable of
producing a PNAG-type biofilm on hydrophobic polystyrene
when grown in BHI NaCl, but can produce a complex biofilm
dependent not only on PNAG but also protein adhesin(s) and
eDNA on hydrophobic polystyrene in BHI glucose media [7].
Contribution of the icaADBC, fnbAB, atl and srtA loci to
8325-4 pmecA HoR biofilm phenotype
To investigate the genetic basis for protein-mediated biofilm in
8325-4 pmecA HoR, the pmecA plasmid was transformed into
fnbAB::Tc
r, atl::Cm
r and srtA::Tc
r derivatives of 8325-4 and
homogeneous oxacillin resistant variants were isolated as described
above. Biofilm assays revealed that HoR derivatives of 8325-4
icaADBC::Tc
r, 8325-4 fnbAB::Tc
r, 8325-4 atl::Cm
r and 8325-4
srtA::Tc
r exhibited a similar biofilm phenotype to 8325-4 pmecA
HoR (Figure 3A). These data strongly suggest that the biofilm
phenotypic switch associated with acquisition of oxacillin resis-
tance is not dependent on PNAG, LPXTG cell wall anchored
proteins (including FnBPA, FnBPB and Protein A) or the major
autolysin.
This raised the possibility that overexpression of the PBP2a
protein itself may promote biofilm development in BHI glucose.
Consistent with this, commercial monoclonal antibodies (Calbio-
chem) to PBP2a reduced biofilm production by 8325-4 pmecA
HoR by up to 50% (P,0.05)(Figure 3B). Biofilm production by
8325-4 Dspa pmecA HoR was also inhibited by the PBP2a antibody
in a concentration dependent manner (Figure 3B), ruling out any
non-specific interference due to antibody binding to Protein A. In
contrast the PBP2a monoclonal antibody had no significant effect
on PNAG-dependent biofilm production by the plasmid-cured
8325-4 pmecA HoR strain (Figure 3B). These data directly
implicate the PBP2a protein in 8325-4 pmecA HoR biofilm
development. However it is important to note that the failure of
the pmecAS403A plasmid to complement biofilm production in the
BH1CC SCCmec strain (Figure 1A) also suggests that PBP2a-
induced oxacillin resistance is required for the PBP2a-mediated
biofilm phenotype
Repression of PNAG production in 8325-4 pmecA HoR
Comparison of 8325-4, 8325-4 pmecA HeR and 8325-4 pmecA
HoR on Congo red agar revealed that the acquisition of
homogeneous resistance was associated with a switch from a crusty
to a smooth colony morphology, which is indicative of reduced
PNAG production (data not shown). Accordingly immunoassays
demonstrated that, unlike 8325-4 and 8325-4 pmecA HeR, PNAG
was not produced by 8325-4 pmecA HoR (Figure 4A). Interestingly
PNAG production was restored in the cured 8325-4 HoR strain
(Figure 4A). Using real time RT-PCR, a .300-fold repression of
icaADBC transcription was measured in 8325-4 pmecA HoR
compared to 8325-4 (Figure 4B). Furthermore wild type levels of
icaADBC transcription were restored in the plasmid-cured 8325-4
pmecA HoR strain (Figure 4B). Transcriptional activity of icaR was
similar in both strains (Figure 4C). In addition genome sequencing
of 8325-4 pmecA HoR confirmed the absence of any mutations in
any known ica operon transcriptional regulator. Thus homogeneous
oxacillin resistance alters the biofilm phenotype by repressing
icaADBC transcription and PNAG production.
Repression of extracellular protease production and Agr
activity in 8325-4 pmecA HoR
Assays of protease activity in culture supernatants revealed an
approximately 2-fold reduction in protease levels in 8325-4 pmecA
Figure 3. Contribution of PBP2a to the S. aureus biofilm
phenotype. (A) Biofilm phenotypes of 8325-4 DicaADBC::Tc
r pmecA
HoR, 8325-4 DsrtA::Em
r pmecA HoR, 8325-4 DfnbAB::Tc
r pmecA HoR,
8325-4 Datl::Cm
r pmecA HoR and 8325-4 pmecA HoR (control) grown for
24 h at 37uC in BHI, BHI NaCl and BHI glucose in hydrophilic 96-well
polystyrene plates. (B) Biofilm production by 8325-4 pmecA HoR, 8325-4
pmecA HoR (cured) and 8325-4 Dspa pmecA HoR (control) grown in the
presence of monoclonal anti-PBP2a antibody. Biofilms were grown at
37uC for 24 h in BHI glucose in hydrophilic 96-well polystyrene plates
using monoclonal anti-PBP2a antibody. Experiments were repeated
three times and average data are shown.
doi:10.1371/journal.ppat.1002626.g003
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8325-4 HoR strain (Figure 5A). Because extracellular protease
activity is subject to regulation by the accessory gene regulator
(Agr) system, we used real time RT-PCR to compare RNAIII
transcript levels in these strains. These data revealed that RNAIII
expression was significantly repressed in 8325-4 pmecA HoR grown
to both the exponential and stationary phases of growth
(Figure 5B). Genome sequence analysis confirmed the absence of
any mutations in the agr locus of 8325-4 pmecA HoR. Thus the
homogeneous oxacillin resistance phenotype in 8325-4 is associ-
ated with repression of the Agr system and extracellular protease
production, both of which are consistent with PBP2a-mediated
biofilm development by 8325-4 pmecA HoR. Furthermore these
data correlate with our earlier observation that protease activity
Figure 4. Impact of homogeneous oxacillin resistance on PNAG
production in 8325-4. (A) Immunoblot analysis of PNAG production
in whole cell extracts of 8325-4, 8325-4 pmecA HeR, 8325-4 pmecA HoR
and 8325-4 pmecA HoR (cured) grown overnight at 37uC in BHI, BHI
NaCl and BHI glucose. (B and C) Comparison of relative icaA (B) and icaR
(C) transcription by real time RT-PCR in 8325-4, 8325-4 pmecA HeR,
8325-4 pmecA HoR and 8325-4 pmecA HoR (cured). Total RNA was
extracted from cultures grown at 37uCt oA600=1 (early exponential
phase) in BHI glucose. Experiments were repeated at least three times
and standard deviations are indicated. Statistical significance (p value) is
indicated.
doi:10.1371/journal.ppat.1002626.g004
Figure 5. Impact of homogeneous oxacillin resistance on
protease activity and expression of the accessory gene
regulator locus in 8325-4. (A) Protease activity in culture superna-
tants of 8325-4, 8325-4 pmecA HeR, 8325-4 pmecA HoR and 8325-4
pmecA HoR (cured) grown for 8 h at 37uC in BHI glucose. (B)
Comparison of relative RNAIII transcription by real time RT-PCR in
8325-4, 8325-4 pmecA HeR, 8325-4 pmecA HoR and 8325-4 pmecA HoR
(cured). Total RNA was extracted from cultures grown at 37uCt o
A600=1 (early exponential phase) and for 8 hours (late exponential/
early stationary phase; A600<8) in BHI glucose. Experiments were
repeated at least three times and standard deviations are indicated.
Statistical significance (p value) is indicated.
doi:10.1371/journal.ppat.1002626.g005
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(Figure 1B).
Homogeneous methicillin resistance attenuates virulence
in 8325-4
Because 8325-4 and 8325-4 pmecA HoR express PNAG-
dependent and PNAG-independent biofilm phenotypes, respec-
tively, their virulence was compared using an established mouse
model of device-related infection [39,40]. Briefly two 1-cm
segments of 14-gauge polyethylene intravenous catheter were
implanted subcutaneously per mouse. In total four groups of eight
mice were inoculated with bacterial cell suspensions of 1610
7 or
1610
8 of either 8325-4 or 8325-4 pmecA HoR, injected directly
into the catheter. These experiments revealed a significantly
higher mortality rate among mice inoculated with 8325-4
compared to 8325-4 pmecA HoR (Figure 6). Seven of the eight
mice inoculated with 1610
8 8325-4 died or were euthanized by
Day 4. Similarly only one of seven mice (one mouse failed to
recover from the anesthetic) inoculated with 1610
7 8325-4
survived beyond Day 4 (Figure 6). In contrast all eight animals
inoculated with 1610
7 8325-4 pmecA HoR survived to Day 7 and
six of the eight animals inoculated with 1610
8 8325-4 pmecA HoR
survived to Day 7 (Figure 6).
The high mortality rate associated with infection of 8325-4
made it impossible for us to compare the invasiveness and
dissemination of 8325-4 and 8325-4 pmecA HoR. Thus, the above
experiment was repeated over an 18-hour time period with an
inoculum of 1610
7 bacteria after which all animals were
sacrificed. The implanted catheter sections were aseptically
removed and bacteria associated with the implanted biomaterial
were quantitatively cultured on tryptone soya agar (TSA). In
addition, peri-catheter tissue, liver, kidneys and spleen were
dissected, weighed, homogenized and quantitatively cultured on
TSA, as were bacteria present in blood. These data revealed that
the numbers of adherent bacteria on implanted catheters were
similar for 8325-4 and 8325-4 pmecA HoR (Figure 7A) indicating
that the altered biofilm phenotype expressed by 8325-4 pmecA
HoR does not diminish its ability to colonize implanted devices.
There were significantly more 8325-4 pmecA HoR bacteria in the
peri-catheter tissue than 8325-4 bacteria (Figure 7B). However
significantly fewer 8325-4 pmecA HoR bacteria were recovered
from the liver, blood, spleen and kidneys than 8325-4 bacteria
(Figure 7 C–F). Thus, these findings are consistent with the
mortality data and indicate that 8325-4 is significantly more
invasive than 8325-4 pmecA HoR, which accumulated in the peri-
catheter tissue and was less capable of disseminating to other
organs.
The immune response of the mice to 8325-4 and 8325-4 pmecA
HoR was measured by assaying levels of TNF-a and IL-6 in the
peri-catheter tissue. Levels of both pro-inflammatory cytokines
were significantly increased in mice inoculated with 8325-4
compared to 8325-4 pmecA HoR (Figure 8), despite the fact that
there were more 8325-4 pmecA HoR cells recovered from the tissue
(Figure 7B). Taken together these data reveal that homogeneous,
high-level resistance to oxacillin significantly attenuated the
virulence of 8325-4.
Impact of homogeneous methicillin resistance on biofilm
production and d-hemolytic activity in clinical isolates of
S. aureus
To investigate the impact of homogenous methicillin resistance
on biofilm production and Agr activity in clinical S. aureus isolates,
we first introduced pmecA into the MSSA strains MSSA476 and
15981 and isolated HoR derivatives on media containing oxacillin
100 mg/ml. As observed in 8325-4, acquisition of the HoR
phenotype in MSSA476 and 15981 was associated with repression
of polysaccharide-type biofilm production and expression of a
protein adhesin-mediated biofilm phenotype (Figure S4). Further-
more the MSSA476 and 15981 HoR strains exhibited reduced d-
hemolytic activity on sheep blood BHI agar (Figure S4). Given
that the d-hemolysin is encoded by the hld gene within the agr locus
RNAIII transcript [41], these data indicate that the HoR
phenotype in MSSA476 and 15981 is accompanied by repression
of Agr activity.
The impact of the HoR phenotype on biofilm production by the
CA-MRSA USA300 strain LAC was also examined. In our
experiments this strain formed a protein-adhesin type biofilm in
BHI glucose media (Figure S5A). A LAC HoR derivative isolated
on media containing oxacillin 100 mg/ml produced significantly
more biofilm (Figure S5A) and exhibited reduced d-hemolytic
activity on sheep blood BHI agar (Figure S5B). Finally we
examined the impact of the HoR phenotype on three CC5 strains
with different SCCmec elements exhibiting a heterogeneous
pattern of oxacillin resistance, namely DAR173, DAR26 and
DAR9. These strains produced a polysaccharide-type biofilm,
whereas their HoR derivates isolated on media containing
oxacillin 100 mg/ml produced protein adhesin-type biofilms and
exhibited reduced d-hemolytic activity (Figure S5C–K).
In the laboratory strain 8325-4, non-synonymous SNPs in gdpP
were associated with the HoR phenotype. Similarly, DNA
sequencing of the gdpP gene from the USA300 LAC HoR
derivative identified an R450STOP mutation. GdpP amino acid
substitutions were also identified in HoR derivatives of the clinical
isolates 15981 (P392S, D105N), MSSA476 (V52I, D105N, P392S) and
DAR26 (N105D, S392P). However these latter substitutions occur
in GdpP residues that are not conserved in multiple S. aureus
species and so their significance is unclear. No gdpP mutations were
identified in HoR derivatives of the clinical isolates DAR176 and
DAR9 suggesting that the HoR phenotypes of these strains may be
independent of c-di-AMP or that these strains contain unidentified
mutations in c-di-AMP target genes.
Discussion
Antibiotic resistance, enzyme and toxin production, biofilm
forming capacity and immune evasion capability have combined
Figure 6. Impact of homogeneous oxacillin resistance on
survival in a mouse device-related S. aureus infection model.
1-cm segments of 14-gauge polyethylene intravenous catheter were
implanted into male 6-week old C57BL/6 mice (2 per mouse) and
injected with 1610
7 or 1610
8 8325-4 and 8325-4 pmecA HoR. Survival
of the animals over seven days is plotted as a percentage of total
numbers (n=8 mice per group except for 8325-4 (1610
7) where n=7
mice).
doi:10.1371/journal.ppat.1002626.g006
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human pathogen. Our recent research has focused on the
relationship between two of these virulence determinants,
antibiotic resistance and biofilm-forming capacity, in clinical S.
aureus isolates. Our data show that MSSA clinical isolates are more
likely to produce a PNAG-dependent biofilm than MRSA isolates
Figure 7. Catheter colonisation and dissemination of 8325-4 and 8325-4 pmecA HoR in a mouse device-related infection model.
Implanted catheter segments were injected with 1610
7 8325-4 and 8325-4 pmecA HoR and animals (n=8 mice per group) were sacrificed after
18 hours. Colony forming units (CFU) per catheter (A), per g peri-catheter tissue (B), per g liver (C), per ml blood (D), per g spleen (E) and per g kidney
(F) recovered from animals infected with 8325-4 and 8325-4 pmecA HoR. Statistical significance (p values) is indicated.
doi:10.1371/journal.ppat.1002626.g007
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ing that methicillin susceptibility influences biofilm expression.
MRSA strains contain the Staphylococcus cassette chromosome mec
(SCCmec) including the mecA gene, which encodes the PBP2a
protein that confers resistance to b-lactam antibiotics. To
investigate how methicillin resistance influences the biofilm
phenotype we introduced a plasmid expressing the mecA gene
from its own promoter (pmecA) into the PNAG-producing
laboratory strain 8325-4. 8325-4 pmecA exhibited heterogeneous
resistance to oxacillin (designated 8325-4 pmecA HeR) from which
an homogeneous, high-level oxacillin resistant derivative was
isolated, designated 8325-4 pmecA HoR. Western blots show that
expression of homogeneous resistance was associated with
substantially increased expression of PBP2a. Genome re-sequenc-
ing identified a number of amino acid substitutions and small
deletions in the gdpP gene of independent 8325-4 HoR strains and
in HoR derivatives of the clinical isolates USA300 strain LAC,
MSSA476, 15981 and DAR26. GdpP has recently been identified
as a phosphodiesterase controlling intracellular levels of the
secondary messenger c-di-AMP, which in turn influences pheno-
types such as cell wall architecture, biofilm formation and, most
relevant to this study, resistance/tolerance to b-lactam antibiotics
[37,38]. Thus c-di-AMP may be involved in the multiple
phenotypic changes associated with homogeneous oxacillin
resistance. However, given that the GdpP amino acid sequence
is identical in 8325-4 (MSSA), USA300 strain LAC (HeR MRSA)
and BH1CC (HoR MRSA), mutations in gdpP and/or altered c-di-
AMP signaling alone may not be sufficient to explain the HeR to
HoR transition. Furthermore no gdpP SNPs were identified in
HoR derivatives of two clinical isolates (DAR9 and DAR176)
suggesting that either these strains contain mutations in c-di-AMP
target genes or that c-di-AMP-independent mechanisms may also
be involved in the HoR phenotype. In this context our recent
finding that loss of methicillin resistance in the HoR MRSA strain
BH1CC reduced biofilm forming capacity and increased virulence
in a mouse sepsis model [42], also indicates that altered c-di-AMP
levels alone are unlikely to account for the pleiotropic effects of the
HoR phenotype. Clearly homogenous methicillin resistance
remains a complex phenotype and future research to identify c-
di-AMP targets is necessary to gain mechanistic insights into how
this cyclic dinucleotide contributes to the co-regulation of
antibiotic resistance, biofilm and virulence.
The biofilm phenotype of 8325-4 pmecA HoR was dramatically
altered and characterized by the loss of PNAG production and
expression of a protein-adhesin mediated biofilm phenotype.
Using a series of surface protein mutants, we were able to show
that the PBP2a-induced biofilm phenotype was independent of
PNAG, Atl, and any of the LPXTG-anchored surface proteins
(including the FnBPs and protein A). Furthermore, a monoclonal
antibody against PBP2a reduced 8325-4 pmecA HoR biofilm
production by approximately 50% implicating PBP2a itself in
intercellular accumulation. The inability of the PBP2a antibody to
fully inhibit 8325-4 pmecA HoR biofilm may be explained, at least
in part, by our observation that this biofilm phenotype was also
dependent on autolytic activity and extracellular DNA. We have
previously implicated autolytic activity and eDNA in the early
stages of PNAG-independent biofilm phenotypes expressed by S.
aureus clinical isolates [6,7]. In contrast biofilm expression by 8325-
4p mecA HeR was similar to wild type, indicating that high level
PBP2a expression is required to change the biofilm phenotype. In
the MRSA strain BH1CC, excision of SCCmec and induced
methicillin susceptibility also resulted in an impaired biofilm
phenotype that could be complemented by the wild type mecA gene
but not a mecA allele expressing a PBP2a mutant with an S403A
substitution in the active site of the enzyme. Taken together, these
data suggest that both high level PBP2a expression and methicillin
resistance are required for the PBP2a-induced biofilm phenotype.
In addition, because Atl/FnBP-dependent biofilm development by
BH1CC was unaffected by PBP2a antibody (data not shown), our
data also reveal redundancy among S. aureus surface proteins that
can promote biofilm development.
How PBP2a promotes biofilm is uncertain but possibly the
altered cell wall architecture in methicillin resistant strains
expressing high levels of PBP2a may facilitate PBP2a-promoted
cell-cell interactions that are not possible between MSSA cells.
What is clear, however, is that high level PBP2a expression
resulted in significant repression of icaADBC transcription and
PNAG production in 8325-4 pmecA HoR (Figure 9). Comparison
of acetic acid levels in 8325-4 and 8325-4 pmecA HoR culture
supernatants revealed no significant difference (data not shown)
suggesting that altered TCA cycle activity, which is known to
regulate PIA/PNAG production [43,44], may not be involved in
this phenotype. PBP2a overexpression also resulted in significant
repression of the agr locus. These data are supported by our recent
findings that excision of the SCCmec element from the MRSA
strain BH1CC and loss of oxacillin resistance had the opposite
effect and was associated with increased agr transcription [42].
Furthermore our previous data showed that MRSA cells are
unable to detect the Agr-encoded auto-inducing peptide (AIP),
thus preventing normal activation of the Agr system and
concomitant virulence gene regulation [42]. However this does
not explain why the icaADBC locus is repressed in strains
expressing high levels of PBP2a. Given that both the agr and ica
loci are repressed by PBP2a expression, it seems possible that a
transcriptional regulator(s) involved in regulating both operons
may also play a role in this phenotype. For instance preliminary
data indicate that the activity of the virulence and carbon
metabolism regulator CcpA, which is known to increase oxacillin
resistance levels [45,46], was activated approx 4-fold in 8325-4
pmecA HoR (unpublished findings). On the other hand CcpA
positively regulates both icaADBC and agr expression [45,46],
suggesting that the impact of PBP2a overexpression on biofilm and
virulence is complex and experiments are underway to investigate
the potential involvement of other transcription factors.
Repression of the Agr locus in response to homogenous
methicillin resistance was accompanied by down-regulation of
Figure 8. Enzyme-linked immunosorbent assay (ELISA) of TNF-
a and IL-6 in peri-catheter tissue recovered from mice (n=7
mice per group) infected for 18 h with 8325-4 and 8325-4
pmecA HoR. Statistical significance (p values) is indicated.
doi:10.1371/journal.ppat.1002626.g008
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activity has previously been shown to alter murein hydrolase
activity and in turn biofilm [35], which appears to correlate with
our finding implicating autolytic activity in the 8325-4 pmecA HoR
biofilm phenotype. Thus repression of extracellular proteases
combined with high level PBP2a expression and methicillin
resistance appears to be required for PBP2a-mediated biofilm
development in 8325-4. Consistent with this, activation of agr
following excision of SCCmec from BH1CC increased production
of extracellular toxins [42]. Here we have shown that loss of
SCCmec also increased extracellular protease production in
BH1CC, which in turn correlated with diminished Atl/FnBP-
promoted biofilm forming capacity. It is also interesting to note
that extracellular protease activity was similar in both 8325-4
pmecA HoR and BH1CC SCCmec pmecA, which both express a
mecA-promoted biofilm phenotype and that as mentioned above
BH1CC does not display the characteristic stationary phase
induction of RNAIII typical of agr
+ strains [42]. Taken together
these data indicate that the capacity of PBP2a to promote biofilm
is dependent, at least in part, on the background levels of
extracellular protease activity in individual strains.
The altered biofilm phenotype and repression of agr in 8325-4
pmecA HoR was accompanied by a significant reduction in
virulence in a mouse model of device-related infection. This
finding correlated with our previous data that the virulence of
BH1CC was increased following excision of SCCmec in a mouse
sepsis model [42]. Thus using two different strains and two
different mouse infection models, our data indicate that expression
of methicillin resistance reduces virulence potential in S. aureus.
Furthermore although the 8325-4 pmecA HoR strain was equally
capable of colonizing implanted biomaterials, it accumulated
significantly more in peri-catheter tissue but was significantly less
capable of causing invasive disease, resulting in a significantly
reduced mortality rate than the wild type 8325-4. An intriguing
backdrop to our findings are the recent reports that psm-mec locus,
which is located adjacent to the mecA locus on type II SCCmec
elements, also represses virulence and promotes the S. aureus
biofilm phenotype [26,27,28]. Thus both mecA-encoded PBP2a
and the psm-mec encoded phenol-soluble modulin-mec (PSM-mec)
can independently repress virulence and promote biofilm in
MRSA. The psm-mec-encoded RNA is able to repress expression of
the chromosomally encoded PSMa, while both the psm-mec RNA
and the PSM-mec protein repress colony spreading ability and
promote biofilm [26,27,28].
Given that healthcare-associated MRSA strains are typically
responsible for infections in immunocompromised patients in
which numerous implanted medical devices are used for organ
and life support and in which the use of antimicrobial drugs is
high, these findings reveal a sophisticated level of adaptation by
MRSA to the hospital environment. The reduced metabolic costs
associated with PBP2a-induced repression of Agr and exoprotein
production coupled with PBP2a-mediated biofilm production,
may confer advantages on MRSA strains. Agr defective strains are
known to be less virulent [48,49] and a number of studies [50,51]
have suggested that, in immunocompromised patients, Agr
defective strains may have advantages including reduced meta-
bolic costs of exoprotein production, increased biofilm production
[52] and increased FnBP expression [53] with resulting effects on
host cell invasion/immune evasion [54]. Indeed biofilm-forming S.
epidermidis strains, which express fewer exoproteins and exotoxins
(and are consequently less virulent), are also significant pathogens
in this patient group. Thus sacrificing virulence for antibiotic
resistance is not necessarily a disadvantage for MRSA and may in
fact benefit the pathogen in this clinical setting. Furthermore
MRSA strains have retained the capacity for biofilm production,
albeit using surface protein adhesins rather than PNAG, which is
Figure 9. Model of PBP2a-mediated modulation of biofilm expression and virulence in S. aureus. High level PBP2a expression and
homogeneous methicillin resistance results in repression of the icaADBC and agr loci blocking PNAG production and reducing expression of
extracellular proteases and cytolytic toxins. Reduced levels of extracellular protease and toxin production in turn correlate with PBP2a-promoted
biofilm development and attenuated virulence.
doi:10.1371/journal.ppat.1002626.g009
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hospital patients are associated with implanted medical devices.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. All
mouse protocols were reviewed and approved by the Institutional
Animal Care and Use Committee at the University of Nebraska
Medical Centre. All surgery was performed under anesthesia and
all efforts were made to minimize suffering.
Bacterial strains, plasmids and growth conditions
The S. aureus strains and the plasmids used in the manipulation
of these strains are described in Table 1. Escherichia coli strains were
grown at 37uC on LB medium supplemented, when required, with
ampicillin (100 mg/ml) or kanamycin (50 mg/ml). S. aureus strains
were grown at 30uCo r3 7 uC on Brain-Heart Infusion (BHI)
(Oxoid) medium supplemented when required with chloramphen-
icol (10 mg/ml), tetracycline (10 mg/ml), kanamycin (10 mg/ml)
and oxacillin (0–100 mg/ml). BHI broth was supplemented where
indicated with 1% glucose or 4% NaCl.
d-haemolytic activity was visualized on sheep blood BHI agar as
described by Traber et al. [41]. Briefly clinical S. aureus isolates
were inoculated onto a lawn of S. aureus RN4220, which produces
only b-haemolysin. The RN4220-expressed b-haemolysin enhanc-
es lysis of red blood cells by d-haemolysin, while inhibiting a-
haemolysin, thus enabling detection of d-haemolytic activity by
clinical S. aureus isolates.
Genetic techniques
Genomic and plasmid DNA was prepared using Wizard
Genomic DNA and plasmid purification kits (Promega). Prior to
DNA extraction cells were pre-treated with 5–10 ml of a 1 mg/ml
Table 1. Strains and plasmids used in this study.
Strain/Plasmid Characteristic(s) Source/reference
8325-4 NCTC8325 cured of prophages. 11-bp deletion in rsbU. [33]
RN4220 Restriction deficient mutant of 8325-4. [64]
SH1000 8325-4 with repaired defect in rsbU. [33]
HG003 NCTC8325 with repaired tcaR and rsbU genes. [36]
8325-4 pmecA HeR 8325-4 carrying pmecA expressing heterogeneous resistance to oxacillin. [42]
8325-4 pmecA HoR 8325-4 carrying pmecA expressing homogeneous resistance to oxacillin. This study
ICA1 DicaADBC::Tc
r; isogenic mutant of 8325-4. [3]
DU5883 fnbA::Tc
r,fnbB::Em
r; isogenic mutant of 8325–4. [65]
SKM1 DsrtA::Em
r; isogenic mutant of RN4220. [66]
JT1392 Datl::Cm
r, isogenic mutant of RN4220. [67]
spa::Km
r spa::Km
r, isogenic mutant of 8325-4. [68]
BH1CC MRSA clinical isolate. Biofilm positive. SCCmec type II, MLST type 8, clonal complex 8. [4]
BH1CC DSCCmec Isogenic mutant of BH1CC lacking SCCmec. [61]
BH10(03) Biofilm positive, homogenoeously methicillin resistant MRSA. SCCmec type IV, clonal complex 22. [4]
DAR13 Biofilm positive, homogenoeously methicillin resistant (HoR) MRSA. SCCmec type IV, clonal complex 8. [4]
DAR168 Biofilm positive, HoR MRSA. SCCmec type I, clonal complex 8. [4]
DAR34 Biofilm positive, HoR MRSA. SCCmec type II, clonal complex 8. [4]
DAR199 Biofilm positive, HoR MRSA. SCCmec type II, clonal complex 30. [4]
DAR112 Biofilm positive, HoR MRSA. SCCmec type III, clonal complex 239. [4]
DAR9 Biofilm positive, heterogeneously methicillin resistant (HeR) MRSA. SCCmec type I, clonal complex 5. [4]
DAR26 Biofilm positive, HeR MRSA. SCCmec type IV, clonal complex 5. [4]
DAR173 Biofilm positive, HeR MRSA. SCCmec type II, clonal complex 5. [4]
MSSA476 Community associated-MSSA. Novel SCC element lacking mecA. [69]
LAC Community associated, HeR MRSA USA300. [35]
15981 Clinical MSSA isolate. Biofilm positive. rsbU
+. [70]
E. coli TOPO recA1 endA1 lac [F9 proAB lac1q Tn10 (tet
r)] Invitrogen
Plasmids
pSR Shuttle vector carrying the SCCmec ccrA and ccrB recombinase genes [15]
pRB474 Low copy E. coli-Staphylococcus shuttle vector. Ap
r (E. coli), Cm
r (Staphylococcus). [71]
pSAmecA5 2,850 bp PCR fragment containing mecA gene amplified using primers SAmecA3 and SAmecA4
and cloned into pCR-Blunt II-TOPO (Invitrogen).
[42]
pmecA 2,867 bp EcoRI fragment containing mecA from pSAmecA5 subcloned into the EcoRI site of pRB474. [42]
pmecAS403A pmecA expressing a PBP2a S403A mutant This study
doi:10.1371/journal.ppat.1002626.t001
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50 mM EDTA to facilitate lysis. Restriction and DNA modifying
enzymes (Roche, UK and New England Biolabs, MA) were used
according to the manufacturer’s instructions. The serine residue at
amino acid 403 in the active site of PBP2a was mutated to alanine
using Phusion polymerase (NEB) and the primers mecAS403A_-
For and mecAS403A_Rev (Table 2). Plasmid pmecA was used as
the template. Successful mutagenesis of the DNA sequence
encoding the S403 residue resulted in the introduction of a new
DraIII restriction enzyme site and candidate plasmids harbouring
the mutation were digested with this enzyme before being
confirmed by sequencing. The mutated plasmid designated
pmecAS403A.
Transformations of plasmid DNA into E. coli and Staphylococcus
strains were performed as described previously [55]. MWG
Biotech, Germany or Sigma-Aldrich, Ireland supplied oligonucle-
otide primers used for PCR and RT-PCR (Table 2).
Biofilm and protease assays
Semi-quantitative measurements of biofilm formation were
determined using Nunclon tissue culture treated (D surface) 96-
well polystyrene plates (Nunc, Denmark), based on the methods of
Christensen et al. [56] and Ziebuhr et al. [57] with the following
modification. Bacteria were grown in individual wells of 96-well
plates at 37uC in BHI medium or BHI supplemented with 4%
NaCl or 1% glucose. The serine protease inhibitor dichloroiso-
coumarin was added to BHI glucose media at concentrations of
0.004–0.5 mM, where indicated. After 24 h of growth, the plates
were washed vigorously three times with distilled H2O to remove
unattached bacteria and dried for 1 hour at 60uC, as recom-
mended by Gelosia et al. [58] as described previously [4,55]. The
absorbance of the adhered, stained biofilms was measured at A492
using a microtitre plate reader. Each strain was tested at least three
times and average results are presented. Mouse monoclonal anti-
PBP2a antibody (CalBioreagents, CA), DNase I (Sigma) or
polyanethole sodium sulfonate (PAS) (Sigma) were added to
biofilm cultures at the start of the assay as indicated. Biofilm
stability against proteinase K (Sigma), sodium-meta-periodate
(Sigma) was tested as described previously [10,59,60].
Bacteria were grown on Congo red agar (CRA) plates, which
are composed of BHI agar supplemented with 5% sucrose (Sigma)
and 0.8 mg of Congo red/ml (Sigma) to distinguish between
PNAG-producing (black, dry colony morphology) and non-
PNAG-producing (red, smooth colony morphology) phenotypes
as described previously [4,55].
Protease activity in culture supernatants was measured using a
protease assay kit (Calbiochem, Germany) according to the
manufacturer’s instructions.
To analyze biofilm formation under flow conditions, we utilized
the BioFlux 1000 microfluidic system (Fluxion Biosciences Inc.,
South San Francisco, CA) which allows automated image
acquisition within specialized multi-well plates. To grow biofilms,
the microfluidic channels were primed with 50% BHI supple-
mented with 4% NaCl or 1% glucose at 10.0 dyn/cm
2. Channels
were seeded at 2 dyn/cm
2 with 10
7 CFU from overnight cultures
of 8325-4 pmecA HeR and 8325-4 pmecA HoR. The plate was then
incubated at 37uC for 1 hour to allow cells to adhere. Excess
inoculums were removed and 2 ml of 50% BHI supplemented
with 4% NaCl or 1% glucose was added to the input wells.
Biofilms were grown at 37uC with a flow of fresh media at a
constant shear of 0.7 dyn/cm
2. Images were taken every
5 minutes for 18 hours at 2006magnification under brightfield.
Isolation and analysis of a homogeneous oxacillin
resistant derivative of S. aureus 8325-4
The pmecA plasmid [61] was introduced by electroporation into
8325-4. The 8325-4 pmecA strain exhibited heterogeneous oxacillin
resistance (HeR) characterized by a minority of cells with an
MIC.100 mg/ml and the majority of cells with an MIC,1 mg/
ml. To obtain high-level oxacillin resistant derivatives, dilutions of
8325-4 pmecA cultures were grown on BHI agar containing
increasing concentrations of oxacillin (0–100 mg/ml) and the
number of colony forming units counted after 24 h growth at
37uC. High-level, homogeneous oxacillin resistant derivatives
(HoR) were subcultured from oxacillin 100 mg/ml plates. Curing
the pmecA plasmid from 8325-4 pmecA HoR was achieved by 48 h
growth in antibiotic free media at 45uC and isolation of
chloramphenicol susceptible colonies followed by plasmid profile
analysis.
The genomes of the 8325-4 pmecA HeR and 8325-4 pmecA HoR
were sequenced using an Illumina Genome Analyzer as per
manufacturer’s instructions (Illumina, San Diego, CA, USA)
generating 5.7 million and 7.5 million reads for 8325-4 pmecA
HoR and 8325-4 pmecA HeR, respectively. The genome sequences
were then mapped back to the S. aureus NCTC8325 (CP000253)
genome sequence using the short read aligner Bowtie (http://
bowtie-bio.sourceforge.net/index.shtml & PMID:19261174) al-
lowing up to 2 mismatches per uniquely mapped read. Single
nucleotide polymorphisms (SNPs) were identified using samtools
programs [PMID:19505943] in regions with a read depth of
greater than 4. Identified SNPs were confirmed by PCR
amplification followed by capillary electrophoresis sequencing of
all candidate polymorphic regions from 8325-4 pmecA HeR and
8325-4 pmecA HoR.
RNA purification and real time RT-PCR
Cultures were grown in BHI glucose after which cells were
collected and immediately stored at 220uC in RNAlater (Ambion)
Table 2. Oligonucleotide primers used in this study.
Target
gene Primer names Primers sequence (59-39)
mecA SAmecA1 AGTTGTAGTTGTCGGGTTTGG
SAmecA2 GCATTGTAGCTAGCCATTCCTT
mecA SAmecA3 TGACGATTCCAATGACGAAC
SAmecA4 GCATCTGGCATGCATACACT
mecA SAmecAFOR TTGGAACGATGCCTATCTCA
SAmecAREV TCCAGGAATGCAGAAAGACC
16S rRNA SA_16S_for ATGCAAGTCGAGCGAAC
SA_16S_rev TGTCTCAGTTCCAGTGTGGC
RNAIII RNAIII_2_for GGAGTGATTTCAATGGCACA
RNAIII_2_rev CATGGTTATTAAGTTGGGATGG
icaA SAicaEON1 TACCTTGCCTAACCCGTAC
SAicaEON2 GTTGGCTCAATGGGGTCTAA
icaR SAicaR1 TTCTCAATATCGATTTGTATTGTCAAC
SAicaR2 TGTCAGGCTTCTTGTTCAATG
mecA mecAS403_For ACAACTTCACCAGGTTGCACTCAAAAAATATTA
mecAS403R_Rev TAATATTTTTTGAGTGCAACCTGGTGAAGTTGT
gdpP gdpP_For CGCATGGTTCAGACGATAAA
gdpP_Rev GCTTCGGCAATTTGTTTTGT
doi:10.1371/journal.ppat.1002626.t002
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were pelleted and resuspended in 100 ml of 200 mM Tris HCl
(pH 7.8) supplemented with 800 mg/ml lysostaphin for 2 min to
weaken the cell wall prior to lysis. Total RNA was subsequently
isolated using the Qiagen RNeasy mini kit (Qiagen) according to
the manufacturer’s instructions. Residual DNA present in the
RNA preparations was removed using Ambion recombinant
Turbo DNase. Purified RNA was eluted and stored in RNAsecure
resuspension solution (Ambion) and the integrity of the rRNA
confirmed by agarose gel electrophoresis. RNA concentration was
determined using a Nanodrop spectrophotometer.
Real-time reverse transcription-PCR (RT-PCR) was performed
on a LightCycler instrument using the RNA amplification kit Sybr
Green I (Roche Biochemicals, Switzerland) following the manu-
facturer’s recommended protocol. RT was performed at 61uC for
30 min, followed by a denaturation step at 95uC for 30 sec and 35
amplification cycles of 95uC for 20 sec, 50uC for 20 sec and 72uC
for 20 sec. Melting curve analysis was performed at 45uCt o9 5 uC
(temperature transition, 0.1uC per sec) with stepwise fluorescence
detection. For LightCycler RT-PCR, RelQuant software (Roche
Biochemicals) was used to measure relative expression of target
genes. 16S rRNA was used as an internal standard in real-time
RT-PCR experiments. Each experiment was performed at least
three times and average data with standard deviations are
presented.
PNAG assays
PNAG assays were performed as described elsewhere [62].
Briefly 5 ml overnight cultures (approximately 5610
9 bacteria)
were collected by centrifugation, resuspended in 500 ml of 0.5 M
EDTA and boiled for 5 min. The cell debris was again centrifuged
and the supernatant treated with 20 mg proteinase K at 65uC for
1 h. The proteinase K was inactivated by boiling for 5 min and
the samples diluted as appropriate before application onto
nitrocellulose (pre-wetted in TBS) using a vacuum blotter. The
blots were dried, re-wet in TBS, and blocked for 1 h in 5%
skimmed milk. The primary antibody (1:5,000 dilution of rabbit
anti-PNAG (a kind gift from Tomas Maira Litran) in TBST+1%
skimmed milk) was then applied to the membrane for 1 h.
Horseradish peroxidase linked anti-rabbit IgG secondary antibody
(1:5,000 dilution in TBST+1% skimmed milk) was then incubated
with the membrane for 1 h. A chemiluminescence kit (Amersham)
was used to generate light via the HRP-catalyzed breakdown of
luminal and detected using a BioRad Fluor-S Max CCD camera
system.
Detection of PBP2a by Western blot
Western blot analysis of PBP2a was performed as described
elsewhere [63] using overnight bacterial cultures (20 ml) grown at
37uC in BHI glucose. The A600 of the overnight cultures was
measured to ensure that similar cell densities were present prior to
protein extraction. The cells were harvested by centrifugation,
washed with 50 mM Tris (Sigma), 150 mM NaCl and 5 mM
MgCl (pH 7.5) and resuspended in the same buffer. Lysostaphin
(200 mg/ml), RNase (10 mg/ml) and DNase (20 mg/ml) were added
to the cell suspension and incubated at 37uC for 30 min. The cells
were disrupted by sonication on ice and the insoluble cell fraction
was pelleted by ultracentrifugation at 800006g for 40 min before
being resuspended in 50 mM sodium phosphate (pH 7.0)
containing 6 M urea.
The membrane proteins (25 mg) were separated using 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis and
electrophoretically transferred onto Immobilon-P membranes
(Millipore) at 12 V for 30 mins. The primary antibody (1:5000
dilution of a mouse anti-PBP2a monoclonal antibody (Denka
Seiken) in TBS+0.1% Tween) was applied to the membranes
overnight. A horseradish peroxidase conjugated anti-mouse IgG
secondary antibody (1:1000 in TBST+1% skim milk) was
incubated with the membranes for 1 hour. A chemiluminescence
kit (Amersham) was used as described above.
Mouse infection experiments
A mouse model of device-related infection [39] was used to
compare virulence of S. aureus 8325-4 and 8325-4 pmecA HoR.
Briefly, the flanks of anesthetized 6-week old male C57BL/6 mice
were shaved, and the skin cleansed with povidone-iodine. Using
aseptic technique, a 1-cm segment of 14-gauge polyethylene
intravenous catheter was implanted into the subcutaneous space
(two per mouse and the incision closed with Vetbond (3M,
Minneapolis, MN). Next, 1610
7 or 1610
8 S. aureus were injected
into the catheter lumen. Eight mice were used to test each
inoculum and strain. Survival over 7 days was measured. Animals
were euthanized before the end of the experiment using the
following indices for evaluating whether a moribund state had
been achieved: extreme lethargy, failure to demonstrate typical
avoidance behaviour when handled, ulceration of the infection site
through the skin, excessive loss of body weight (i.e. .20%), and/or
labored breathing.
The high level of mortality associated with infection of 8325-4
prompted us to repeat the above experiment over 18 hours using
an inoculum of 1610
7 bacteria before sacrificing all animals and
enumerating the numbers of bacteria associated with the catheter,
surrounding tissue, blood, liver, spleen and kidneys. To do this, the
catheters were aseptically removed, placed in sterile microcen-
trifuge tubes with 1 ml of phosphate buffered saline (PBS),
vortexed for one minute, and quantitatively cultured on tryptone
soya agar (TSA). In addition, peri-catheter tissue, liver, kidneys
and spleen were dissected, weighed, homogenized and quantita-
tively cultured on TSA. Finally, bacteria present in blood were also
quantitatively cultured on TSA.
TNF-a and IL-6 levels were measured in the peri-catheter tissue
using TNF-a (OptiEIA, BD Bioscience) or IL-6 (Duoset; R&D
Systems) ELISA kits according to the manufacturer’s instructions.
Results were normalized to the total amount of tissue recovered.
Statistical analysis
Two-tailed, two-sample equal variance Student’s t-tests (Micro-
soft Excel 2007) were used to determine statistically significant
differences in biofilm forming capacity and relative gene
expression.
For the animal experiments descriptive statistics (including
mean, standard deviation, median minimum and maximum)
values were calculated for each strain at each location i.e. catheter,
peri-catheter tissue, blood, liver, spleen and kidneys. Log10
transformation of CFU data from catheter and tissue was used
to ensure normal distribution. A two-sample t-test was conducted
to compare the log-transformed CFU values for 8325-4 and 8325-
4p mecA HoR from either catheter or peri-catheter tissue.
Nonparametric Wilcoxon rank sum tests were used to compare
8325-4 and 8325-4 pmecA HoR CFU data from blood, liver, spleen
and kidneys.
Supporting Information
Figure S1 Biofilm phenotypes of DAR13 (CC8, SCCmec type
IV), DAR168 (CC8, SCCmec type I), DAR34 (CC8, SCCmec type
II), BH10(03) (CC22, SCCmec type IV), DAR199 (CC30, SCCmec
type II) and DAR112 (CC239, SCCmec type III), together with
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complemented with pmecA. Biofilms were grown for 24 h at 37uC
in BHI glucose in hydrophilic 96-well polystyrene plates. The data
presented are the average of three independent experiments and
standard deviations are shown.
(TIF)
Figure S2 Immunoblot analysis of PNAG production in whole
cell extracts of 8325-4, HG003 and 8325-4 DicaADBC grown
overnight at 37uC in BHI media.
(TIF)
Figure S3 Biofilm formation by 8325-4 pmecA HeR and 8325-4
pmecA HoR under flow conditions after 15 h growth in BHI
glucose or BHI NaCl. Biofilms were grown in a BioFlux 1000
microfluidics system. Images were taken at 2006 magnification
under brightfield illumination.
(TIF)
Figure S4 Impact of homogeneous oxacillin resistance on the
biofilm phenotypes and d-hemolytic activity of the MSSA strains
15981 and MSSA476. (A) Biofilm phenotypes of 15981, 15981
pmecA HeR, 15981 pmecA HoR and 15981 pmecA HoR (cured). (B)
d hemolytic activity of 15981 pmecA HeR and 15981 pmecA HoR
on sheep blood agar (C) Dispersal of 5981, 15981 pmecA HeR,
15981 pmecA HoR and 15981 pmecA HoR (cured) biofilms by
sodium metaperiodate and proteinase K. (D) Biofilm phenotypes
of MSSA476, MSSA476 pmecA HeR, MSSA476 pmecA HoR and
MSSA476 pmecA HoR (cured). (E) d hemolytic activity of
MSSA476 pmecA HeR and MSSA476 pmecA HoR on sheep blood
agar. (F) Dispersal of MSSA476, MSSA476 pmecA HeR,
MSSA476 pmecA HoR and MSSA476 pmecA HoR (cured) biofilms
by sodium metaperiodate and proteinase K. All biofilms were
grown for 24 h in BHI, BHI NaCl and BHI glucose on
hydrophilic polystyrene. Experiments were repeated three times
and average data are shown.
(TIF)
Figure S5 Impact of homogeneous oxacillin resistance on the
biofilm phenotypes and d-hemolytic activity of HeR MRSA
strains. (A) Dispersal of USA300 strain LAC and USA300 strain
LAC HoR biofilms by sodium metaperiodate and proteinase K.
(B) d hemolytic activity of USA300 HeR and USA300 HoR on
sheep blood agar. (C and D) Dispersal of DAR26 wild type (HeR,
CC5, SCCmec type IV) and DAR26 HoR biofilms by sodium
metaperiodate and proteinase K. (E) d hemolytic activity of
DAR26 HeR and DAR26 HoR on sheep blood agar. (F and G)
Dispersal of DAR173 wild type (HeR, CC5, SCCmec type II) and
DAR173 HoR biofilms by sodium metaperiodate and proteinase
K. (H) d hemolytic activity of DAR173 HeR and DAR173 HoR
on sheep blood agar. (I and J) Dispersal of DAR9 wild type (HeR,
CC5, SCCmec type and DAR9 HoR biofilms by sodium
metaperiodate and proteinase K. (K) d hemolytic activity of
DAR9 HeR and DAR9 HoR on sheep blood agar. HoR strains
were isolated and cultured in oxacillin 100 mg/ml-supplemented
media. USA300 strain LAC biofilms were grown in BHI glucose
only. DAR26, DAR173 and DAR9 biofilms were grown in BHI,
BHI NaCl and BHI glucose. All biofilms were grown for 24 h at
37uC on hydrophilic polystyrene. Experiments were repeated
three times and average data are shown.
(TIF)
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